Real life efficacy and tolerability of Tenofovir Alafenamide Fumarate in patients with hepatitis-B virus-related cirrhosis

被引：0
|
作者：
Yapali, Suna [1 ]
Gokcan, Hale [2 ]
Durak, Serdar [3 ]
Ellik, Zeynep Melekoglu [2 ]
Guzelbulut, Fatih [4 ]
Vatansever, Sezgin [5 ]
Ari, Derya [6 ]
Mehdiyev, Shahin [7 ]
Adanir, Haydar [8 ]
Koc, Elif Sitre
Gunduz, Feyza [7 ]
Arslan, Mehmet [3 ]
Ozdil, Kamil [9 ]
Dincer, Dinc [8 ]
Idilman, Ramazan [2 ]
机构：
[1] Acibadem Univ, Istanbul, Turkey
[2] Ankara Univ, Med Sch, Ankara, Turkey
[3] KTU Fac Med, Trabzon, Turkey
[4] SBU Haydarpasa Numune Egitim & Arastirma Hastane, Istanbul, Turkey
[5] Katip Celebi Univ, Izmir, Turkey
[6] Ankara Sehir Hastanesi, Ankara, Turkey
[7] Marmara Univ, Res & Educ Hosp, Istanbul, Turkey
[8] Akdeniz Univ, Antalya, Turkey
[9] Saglik Bilimleri Univ, Umraniye Egitim & Arastirma Hastanesi, Istanbul, Turkey
来源：
JOURNAL OF HEPATOLOGY | 2022年 / 77卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT421
引用
收藏
页码：S864 / S864
页数：1
相关论文
共 50 条
  • [21] Real-World Single-Center Comparison of the Safety and Efficacy of Entecavir, Tenofovir Disoproxil Fumarate, and Tenofovir Alafenamide in Patients with Chronic Hepatitis B
    Jeong, Sara
    Shin, Hyun Phil
    Kim, Ha Il
    INTERVIROLOGY, 2022, 65 (02) : 94 - 103
  • [22] Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarate
    Kaneko, Shun
    Kurosaki, Masayuki
    Tamaki, Nobuharu
    Itakura, Jun
    Hayashi, Tsuguru
    Kirino, Sakura
    Osawa, Leona
    Watakabe, Keiya
    Okada, Mao
    Wang, Wan
    Shimizu, Takao
    Higuchi, Mayu
    Takaura, Kenta
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Takahashi, Yuka
    Watanabe, Mamoru
    Izumi, Namiki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (11) : 2004 - 2010
  • [23] Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide
    Hong, Hyeyeon
    Choi, Won-Mook
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Choi, Jonggi
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (01) : 49 - 63
  • [24] Effects of tenofovir alafenamide fumarate on serum lipids in patients with chronic hepatitis B
    Liu, Yilin
    Wang, Jian
    Zhang, Zhiyi
    Zhang, Yao
    Ding, Weimao
    Zhu, Chuanwu
    Huang, Rui
    Wu, Chao
    Li, Jie
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1080 - S1081
  • [25] Real life efficacy, renal and lipid profile data of tenofovir alafenamide in switched chronic hepatitis B patients
    Guner, Rahmet
    Yoruk, Gulsen
    Karabay, Oguz
    Yamazhan, Tansu
    Baykam, Nurcan
    Yildirim, Mustafa
    Ince, Nevin
    Yildiz, Ilknur Esen
    Dokmetas, Ilyas
    Koc, Melihe Meric
    Koksal, Iftihar
    Kose, Sukran
    Ceken, Sabahat
    Inan, Dilara
    Bozkurt, I.
    Turker, Kamuran
    Celebi, Guven
    Batirel, Ayse
    Unlu, Gulten
    Gunal, Ozgur
    Gorenek, Levent
    Sirmatel, Fatma
    Sener, Alper
    Parlak, Emine
    Tabak, Fehmi
    JOURNAL OF HEPATOLOGY, 2022, 77 : S858 - S859
  • [26] Efficacy of telbivudine compared with entecavir in hepatitis B virus-related cirrhosis
    Yim, Hyung Joon
    Kim, Hae Rim
    Kang, Seong Hee
    Yoon, Eileen L.
    Lee, Hyun Jung
    Suh, Sang Jun
    Kim, Ji Hoon
    Seo, Yeon Seok
    Yeon, Jong Eun
    Um, Soon Ho
    Byun, Kwan Soo
    HEPATOLOGY, 2013, 58 : 687A - 688A
  • [27] Cardiac health in patients with hepatitis B virus-related cirrhosis
    Yuan, Wei
    Lu, Hong-Zhou
    Mei, Xue
    Zhang, Yu-Yi
    Zhang, Zheng-Guo
    Zou, Ying
    Wang, Jie-Fei
    Qian, Zhi-Ping
    Guo, Hong-Ying
    MEDICINE, 2019, 98 (13)
  • [28] Switching from combination therapy with entecavir hydrate plus tenofovir alafenamide fumarate to tenofovir alafenamide fumarate monotherapy in patients with chronic hepatitis B based on nucleotide sequences of hepatitis B virus pregenome RNA
    Yamada, Shunsuke
    Uchida, Yoshihito
    Kouyama, Jun-Ichi
    Naiki, Kayoko
    Tsuji, Shohei
    Uemura, Hayato
    Sugawara, Kayoko
    Nakayama, Nobuaki
    Imai, Yukinori
    Tomiya, Tomoaki
    Mizuno, Suguru
    Mochida, Satoshi
    HEPATOLOGY RESEARCH, 2024, 54 (10) : 877 - 887
  • [29] EFFECTS OF TENOFOVIR ALAFENAMIDE FUMARATE VERSUS TENOFOVIR DISOPROXIL FUMARATE ON SERUM LIPID PROFILES IN PATIENTS WITH CHRONIC HEPATITIS B
    Cao, Fei
    Fan, Tao
    Jiang, Xue
    Wang, Jian
    Xiong, Ye
    Zhang, Shaoqiu
    Zhang, Zhiyi
    Liu, Xingxiang
    Zhu, Chuanwu
    Li, Jie
    Huang, Rui
    Wu, Chao
    HEPATOLOGY, 2024, 80 : S298 - S298
  • [30] REAL WORLD COMPARISON OF RENAL SAFETY IN PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE VS TENOFOVIR ALAFENAMIDE FOR CHRONIC HEPATITIS B
    Zhang, Xueyun
    Hu, Qiankun
    Liu, Xiaoqin
    Huang, Yuxian
    HEPATOLOGY, 2021, 74 : 490A - 491A
12345